The controversial former pharma executive Martin Shkreli pleaded not guilty to another federal charge on Monday, according to Reuters.
Shkreli was hit on Friday with a new indictment that included a new conspiracy charge. The charges are related to allegations that Shkreli and his former attorney Evan Greebel took stock from one company to prop up another.
The charges aren’t related to Shkreli’s infamous decision while CEO at Turing Pharmaceuticals to raise the price of an anti-malarial drug Daraprim by 5,000 percent. The drastic hike from $13.50 a pill to $750 a pill sparked national outrage.
Shkreli was originally indicted back in December for a collection of related securities fraud charges and pleaded not guilty to those charges as well.
The charges are related to the biotech firm Retrophin that Shkreli helmed before forming Turing. Shkreli allegedly took assets from his hedge funds to make Retrophin look more attractive to investors.
On Friday, Shkreli was asked to respond to the charges while on Twitter by a Bloomberg reporter. He curtly responded, “don’t make me slap you.”
He later tweeted a quote from his attorney, Benjamin Brafman, that said the new charges don’t have any merit.
